Pro-inflammatory cytokines, such as interleukin-6 (IL-6), have been implicated in the underlying processes contributing to sleep regulation and fatigue. Despite evidence for sleep difficulties, fatigue, and elevations in IL-6 among women with ovarian cancer, the association between these symptoms and IL-6 has not been investigated. To address this knowledge gap, we examined relationships between sleep disturbance, fatigue, and plasma IL-6 in 136 women with ovarian cancer prior to surgery. These relationships were also examined in 63 of these women who were disease-free and not receiving chemotherapy one year post-diagnosis. At both time-points, higher levels of IL-6 were significantly associated with sleep disturbances (p < 0.05), controlling for potentially confounding biological and psychosocial covariates. Higher IL-6 was significantly associated with fatigue prior to surgery (p < 0.05); however, when sleep disturbance was included in the model, the relationship was no longer significant. IL-6 was not significantly associated with fatigue at one year. Changes in sleep over time were significantly associated with percent change in IL-6 from pre-surgery to one year, adjusting for covariates (p < 0.05). These findings support a direct association of IL-6 with sleep disturbances in this population, whereas the relationship between IL-6 and fatigue prior to surgery may be mediated by poor sleep. As this study is the first to examine cytokine contributions to sleep and fatigue in ovarian cancer, further research is warranted to clarify the role of biological correlates of sleep and fatigue in this population.
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Introduction
High levels of both sleep disturbances and fatigue have been documented in women with ovarian cancer (Clevenger et al., under review; Anderson and Hacker, 2008; Sandadi et al., 2011) . The cooccurrence of these symptoms in oncology patients has been well established (Roscoe et al., 2007) and both of these symptoms have been associated with poor quality of life in ovarian (Sandadi et al., 2011; Clevenger et al., under review; Holzner et al., 2003) and other cancer populations (Fiorentino and Ancoli-Israel, 2007; Ancoli-Israel et al., 2001 ).
Although inflammatory cytokines have been associated with both fatigue and sleep disturbances, the role of inflammatory cytokines with respect to these burdensome symptoms has not been investigated in ovarian cancer, a disease characterized by high levels of systemic pro-inflammatory cytokines that are thought to be tumor-derived (Tempfer et al., 1997) . Pro-inflammatory cytokines such as interleukin-1 (IL-1), interleukin-6 (IL-6) and tumor necrosis factor-a (TNF-a) are implicated in the regulation of sleep (Opp and Toth, 2003) , modulation of sleep architecture (Kapás et al., 1992; Opp et al., 1991) , and appear to be involved in circadian regulation of sleep as well (Guess et al., 2009; Vgontzas et al., 2005) . Sleep deprivation increases monocyte production of IL-6 (Irwin et al., 2006) , and a daytime nap decreases IL-6 in individuals with nighttime sleep loss (Vgontzas et al., 2007) , leading to suggestions of a bi-directional feedback loop between sleep and cytokine expression (Irwin, 2002) .
Presence of fatigue has been described as a ''pre-diagnostic symptom'' for ovarian cancer, as it is one of the most commonly
